Trade ABVX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Abivax SA American Depositary Shares (ABVX) is trading at US$118.64, up 2.32% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$10.03B. Over the past 52 weeks, ABVX has traded between US$69.81 and US$148.83. On Syfe you can trade ABVX with $0 commission and add it to your watchlist.
| Previous close | US$115.95 |
|---|---|
| Market cap | US$10.03B |
| 52-week range | US$69.81 – US$148.83 |
| Volume | 893.21K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Abivax SA American Depositary Shares
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
Year: 2023
Abivax's Potential Colitis Drug Showing Positive Results That Bolster Stock Prospects, Morgan Stanley Says
Jul 24, 12:47 PM · MT Newswires
Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating
Jul 24, 9:47 AM · MT Newswires
Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies
Jul 16, 10:08 AM · MT Newswires
Abivax Closes $920 Million ADS Offering
Jul 6, 8:21 PM · MT Newswires
Stay on top of ABVX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
